GEIST:UPC Searchengine

ORD_63909/2024

DexCom, Inc. v. Abbott Diagnostics GmbH, Abbott Diabetes Care Inc., Abbott Laboratories, Abbott Gesellschaft m.b.H., Abbott GmbH, Abbott Scandinavia Aktiebolag, Newyu,Inc., Abbott B.V., Abbott, Abbott S.r.l., Abbott Laboratories A/S, Abbott France, Abbott Logistics B.V., Abbott Oy

Datum
2024-12-11
Kammer
Paris (FR) Local Division
Verfahrensart
Generic Order
Sprache
EN

Metadaten

Fall-IDORD_63909-2024-280e821f8374
Aktenzeichen
RegisterzeichenORD_63909/2024
EntscheidungsreferenzORD_63909/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 27

1 Paris Local Division UPC_CFI_395/2023 Decision on the merits of the Court of First Instance of the Unified Patent Court delivered on 11/12/2024 in an action for infringement with counterclaim for revocation concerning EP3831282 Headnotes: 1. The order pursuant to Rule 36 RoP issued by the judge-rapporteur relates to adding some argu- ments to the debate related to some specific terms regarding claim interpretation, but it did not authorise the defendant to raise a new ground for revocation. The UPC procedure is a front-loaded system and the Court finds no legitimate reason for the defendant, which had already stated its own claim interpretation in its Statement of Defence and counterclaim, to raise a new ground for revocation at a later stage of the proceedings concerning the validity of ...